Cambridge, MA – CluePoints, a leading provider of Risk-Based Monitoring (RBM) and Data Quality Oversight solutions for clinical trials, has appointed Steve Young as Senior Vice President of its US Operations. The appointment marks a key strategic move for the company in optimizing its operational performance, customer support and service delivery across North America.
Young will oversee all US sponsor deliverables including software implementation, professional services, and RBM process consultancy. He will also take responsibility for customer success planning and execution, including working closely with clients to further enhance the use of CluePoints’ Central Statistical Monitoring platform within their organizations.
With a career in clinical research spanning more than 20 years, Young brings unrivaled specialist knowledge to CluePoints, having worked on the sponsor side for J&J, Centocor, Astra-Merck and most recently as Senior Director of Transformation Services for OmniComm Systems, where he was responsible for overseeing and delivering advanced RBM services for clients.
“We are delighted to welcome Steve Young to our team,” said CluePoints’ CEO, Franҫois Torche. “With more and more CROs and BioPharma sponsors embarking on a knowledge transfer process to enable them to be self-sufficient in using RBM software, we are continuously looking to bring the highest level of expertise to our team to ensure our clients have the support and guidance they need during this process.”
“Steve’s experience and reputation within the sector make him the ideal person for this newly established position within CluePoints, and having already worked closely with Steve for a number of years in his previous role, I am confident that he will achieve great success as part of the CluePoints team. Many sponsors look to CluePoints, not only to provide them with THE enabling technology for Risk-Based Monitoring, but also to advise how they should change their internal process to get the best out of their technology choice. We now have the perfect industry Thought Leader to enhance that consultative discussion.”
Commenting on his appointment, Steve Young said: “CluePoints has a fantastic reputation and is at the forefront of RBM, helping some of the most recognized names in the industry to integrate the approach seamlessly into their workflow. I’m very much looking forward to being part of the team and helping CluePoints continue its impressive journey.”
For further information on CluePoints’ solutions, please visit www.cluepoints.com
About CluePoints
CluePoints® is a Central Statistical Monitoring solution that has been designed and perfected over the last 10 years. It employs unique statistical algorithms to determine the quality, accuracy, and integrity of clinical trial data both during and after study conduct. Aligned with guidance from the FDA and EMA, CluePoints® is deployed to support traditional on-site monitoring and to drive a risk-based monitoring strategy. The value of using CluePoints® lies in its powerful and timely ability to identify anomalous data and site errors allowing improvement in clinical data quality, optimization of on-site monitoring and a significant reduction in overall regulatory submission risk.
